Category: news

March 16, 2017 Off

Antibacterial drug resistance: market landscape, challenges and upcoming

By Dino Mustafić

Since the discovery of penicillin in 1948, antibiotics have emerged as a crucial class of pharmacological interventions responsible for treating several infectious conditions. In addition, antibiotics are also used for prophylactic purposes in patients who have undergone surgery, or immunocompromised patients (cancer patients undergoing chemotherapy), a market researcher ReportBuyer said in a report.

March 15, 2017 Off

InDex Pharmaceuticals gets patent grant in USA

By Dino Mustafić

Sweden-based pharmaceutical development company focusing on immunological diseases InDex Pharmaceuticals Holding AB has been granted a patent covering 19 compounds from the company’s DIMS platform by the United States Patent and Trademark Office (USPTO).